What makes these stocks interesting?
Tornier N.V (TRNX) Sees Q4, FY12 Sales Above Consensus
- Projects Q4 sales in the range of $75.8 mln - $78.8 mln. Consensus - $72.47 mln.
- Expects FY12 sales to range between $274 mln and $277 mln. Consensus - $270.98 mln.
***
ExamWorks Group Inc. (EXAM) Expects Q4, FY12 Sales Above Estimates
- Sees Q4 reported revenue to range between $138 mln and $142 mln. Consensus - $136.00 mln.
- Projects FY12 reported revenue in the range of $520 mln - $524 mln.
- Expects FY12 pro forma revenue to range between $575 mln and $579 mln. Consensus - $516.12 mln.
- Expects FY13 organic revenue growth to increase to between 5% and 7%.
***
NeuStar Inc. (NSR) Q3 Profit Rises; Lifts FY12 Earnings View
- Raises FY12 adj. EPS target to $2.94 - $3.03 from prior outlook of $2.78 - $2.90 per share. Consensus - $2.85/Shr.
- Now sees FY12 adj. net income in the range of $200 mln - $206 mln, up from prior view of $189 mln - $197 mln.
- Maintains FY12 revenue guidance at $825 mln - $835 mln. Consensus - $830.93 mln.
***
Pike Electric Corp. (PIKE) Q1 Profit Up, Tops View
- Q1 EPS surged to $0.26 from $0.07 last year. Consensus - $0.12/Shr.
- Q1 net income rose to $9.28 mln from $2.60 mln last year.
- Q1 revenues increased to $244.6 mln from $171.8 mln a year ago. Consensus - $198.37 mln.
***
TransAct Technologies Inc. (TACT) Issues Q4 Guidance
- Sees Q4 EPS, excluding the AVY legal fees, to be at least $0.20. Year ago EPS was $0.06/Shr.
- Projects Q4 revenue to be at least $19 mln. Year ago revenue was $13.65 mln.
***
SBA Communications Corp. (SBAC) Q3 FFO Rises; Lifts FY12 Revenue Outlook
- Projects Q4 adj. FFO in the range of $107 mln - $111 mln.
- Expects Q4 revenues to range between $285.5 mln and $289.5 mln. Consensus - $276.33 mln.
- Lifts FY12 adj. FFO target to $371.4 mln - $375.4 mln from prior outlook of $338 mln - $371 mln.
- Raises FY12 revenue guidance to $945.7 mln - $949.7 mln from prior view of $881 mln - $911 mln. Consensus - $933.77 mln.
- Expects FY13 adj. FFO in the range of $456.0 mln - $476.0 mln
- Sees FY13 revenue to range between $1.16 bln and $1.19 bln. Consensus - $1.18 bln.
***
Performant Financial Corp. (PFMT) Q3 Profit Rises
- Q3 net income rose to $6.4 mln or $0.13/Shr from $3.5 mln or $0.08/Shr last year.
- Q3 adj. net income was $8.1 mln or $0.17/Shr versus $7 mln or $0.16/Shr a year ago.
- Q3 revenues increased 27.1% to $53.4 mln from $42 mln last year.
***
LeapFrog Enterprises Inc. (LF) Q3 Results Tops Estimate; Boosts FY12 Outlook
- Now sees FY12 EPS in the range of $0.75 - $0.81 from prior view of $0.61 - $0.66. Consensus - $0.68/Shr.
- Now expects FY12 net sales to increase 18% - 21% to $535 mln - $550 mln versus prior growth estimate of 13% - 15%. Consensus - $533.88 mln.
***
Andersons Inc. (ANDE) Q3 Profit Rises
- Q3 net income was $16.9 mln or $0.90/Shr versus $10.9 mln or $0.59/Shr last year. Consensus - $0.27/Shr.
- Q3 revenues rose to $1.14 bln from $938.7 mln last year. Consensus - $982.20 mln.
***
Covance Inc. (CVD) Q3 Profit Tops View; Revises FY12 EPS Outlook
- Sees Q4 pro forma EPS to be about $0.70. Consensus - $0.69/Shr.
- Lifts lower-end of FY12 EPS target to a range of $2.65 - $2.70, from prior estimate of $2.50 - $2.70/Shr. Consensus - $2.61/Shr.
***
Fidelity National Financial Inc. (FNF) Q3 Profit Increases
- Q3 net income was $233.3 mln or $1.03/Shr, up from $74.3 mln or $0.33/Shr last year. Consensus - $0.54/Shr.
- Q3 total revenues grew to $2.04 bln from $1.20 bln last year.
***
Rudolph Technologies Inc. (RTEC) Q3 Profit Up On Higher Revenues
- Q3 net income was $6.66 mln or $0.20/Shr versus $5.30 mln or $0.16/Shr last year. Consensus - $0.23/Shr.
- Q3 revenues rose to $62.2 mln from $41.4 mln a year ago. Consensus - $60.15 mln.
***
Myriad Genetics Inc. (MYGN) Q3 Results Top Estimate; Boosts FY13 Outlook
- Lifts FY13 EPS target to $1.50 - $1.55 from prior outlook of $1.44 - $1.48. Consensus - $1.47/Shr.
- Raises FY13 revenue guidance to $570 mln - $585 mln from prior estimate of $550 mln - $565 mln. Consensus - $563.46 mln.
***
Medifast Inc. (MED) Sees Q4 Results Above Consensus
- Expects Q4 EPS to range between $0.23 and $0.25. Consensus - $0.19/Shr.
- Projects Q4 net revenue to increase in the range of 18% - 21% or $82 mln - $84 mln. Consensus - $80.22 mln.
***
BIOLASE Inc. (BIOL) Issues Q4, FY12 Guidance
- Projects Q4 net revenue to be about $16.5 mln - $17.5 mln, reflecting expected growth of 26% - 34% over last year. Consensus - $17.90 mln.
- Expects FY12 non-GAAP adj. gross revenue in the range of $55 mln - $58 mln. Consensus - $56.97 mln.
- Sees FY12 GAAP revenue in the range of $53.9 mln - $56.9 mln.
***
Alon USA Energy Inc. (ALJ) Q3 Profit Rises
- Q3 net income rose to $43.2 mln or $0.76/Shr from $28.6 mln or $0.51/Shr last year.
- Q3 net income, excl. special items, was $47.6 mln or $0.84/Shr, up from $39.0 mln or $0.70/Shr last year. Consensus - $0.64/Shr.
- Q3 net sales were $2.36 bln, up from $2.06 bln generated a year ago. Consensus - $2.05 bln.
***
ePlus inc. (PLUS) Q2 Profit Increases
- Q2 net income rose 42% to $10 mln from $7.1 mln last year.
- Q2 EPS grew 49.4% to $1.27 from $0.85 last year.
- Q2 revenues increased 27.7% to $260.1 mln from $203.7 mln last year.
***
Vectren Corp. (VVC) Q3 Profit Tops Estimate; Boosts FY12 EPS Outlook
- Raises FY12 EPS target to $1.80 - $1.90 from prior guidance of $1.65 - $1.85. Consensus - $1.74/Shr.
For comments and feedback: editorial@rttnews.com